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he arrest of meiotic prophase in mouse oocytes
within antral follicles requires the G protein G
 
s
 
 and
an orphan member of the G protein–coupled recep-
tor family, GPR3. To determine whether GPR3 activates
G
 
s
 
, the localization of G
 
 
 
s
 
 in follicle-enclosed oocytes
from 
 
Gpr3
 
 
 
/
 
 
 
 and 
 
Gpr3
 
 
 
/
 
 
 
 mice was compared by using
immunoﬂuorescence and G
 
 
 
s
 
GFP. GPR3 decreased the
ratio of G
 
 
 
s
 
 in the oocyte plasma membrane versus the
cytoplasm and also decreased the amount of G
 
 
 
s
 
 in the
T
 
oocyte. Both of these properties indicate that GPR3 acti-
vates G
 
s
 
. The follicle cells around the oocyte are also nec-
essary to keep the oocyte in prophase, suggesting that
they might activate GPR3. However, GPR3-dependent G
 
s
 
activity was similar in follicle-enclosed and follicle-free oo-
cytes. Thus, the maintenance of prophase arrest depends
on the constitutive activity of GPR3 in the oocyte, and the
follicle cell signal acts by a means other than increasing
GPR3 activity.
 
Introduction
 
Meiosis begins early in oogenesis but does not proceed beyond
prophase until luteinizing hormone from the pituitary acts on
the somatic cells of the follicle surrounding the oocyte (Eppig
et al., 2004). For the prolonged period of storage before oocyte
growth and during the growth period, meiotic arrest is main-
tained by inherent factors in the oocyte (Eppig et al., 2004).
However, once the oocyte has grown to its full size and an an-
tral space has begun to form between the somatic cells of the
follicle, a different mechanism for maintaining meiotic arrest
comes into play. After this point, the oocyte will resume meiosis
spontaneously if isolated from the follicle, leading to the con-
clusion that maintenance of meiotic arrest requires an inhibi-
tory signal from the follicle cells (Pincus and Enzmann, 1935;
Erickson and Sorensen, 1974).
The inhibitory signal has been proposed to be cAMP
that enters the oocyte from the somatic cells (Anderson and
Albertini, 1976; Piontkewitz and Dekel, 1993; Webb et al.,
2002; Eppig et al., 2004). However, this long-standing hypothe-
sis has recently been challenged by evidence that the regulation
of meiotic arrest requires a G protein, a receptor, and adenylyl
cyclase in the oocyte (Mehlmann et al., 2002, 2004; Horner et
al., 2003; Kalinowski et al., 2004; Ledent et al., 2005). This has
led to the concept that follicle cells control the oocyte cell cycle
by regulating rates of cAMP production or degradation within
the oocyte, but the communication pathway between follicle
cells and the oocyte has not been determined.
The requirement for elevated cAMP in the oocyte to
maintain prophase arrest was established by several findings
(Conti et al., 2002; Eppig et al., 2004; Mehlmann, 2005). (1)
After removal from the antral follicle, the oocyte’s cAMP con-
tent decreases in parallel with meiotic resumption (Tornell et
al., 1990). (2) Isolated oocytes can be maintained in prophase
arrest by elevating cAMP (for example, with membrane per-
meant cAMP analogues or cAMP phosphodiesterase [PDE]
inhibitors; Cho et al., 1974; Schultz et al., 1983; Eppig et al.,
1985). (3) Oocytes within complexes of follicular somatic
cells, which maintain meiotic arrest in vitro, resume meiosis
in response to a permeant cAMP antagonist (Eppig, 1991).
Elevated cAMP maintains meiotic arrest by activating protein
kinase A, which phosphorylates and, thus, inhibits the phos-
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phatase CDC25B; this prevents CDC25B from dephosphory-
lating and activating CDK1 and, therefore, prevents the pro-
phase-to-metaphase transition (Duckworth et al., 2002; Lincoln
et al., 2002).
The cAMP that maintains meiotic arrest is produced in
the oocyte by a pathway requiring the activity of the heterotri-
meric G protein G
 
s
 
 (Mehlmann et al., 2002; Kalinowski et al.,
2004) and type 3 adenylyl cyclase (Horner et al., 2003). Sup-
porting these conclusions, the injection of follicle-enclosed oo-
cytes with a G
 
 
 
s
 
 inhibitory antibody or a dominant-negative
form of G
 
 
 
s
 
 causes meiosis to resume (Mehlmann et al., 2002;
Kalinowski et al., 2004), as does the deletion of the gene for
type 3 adenylyl cyclase, which is expressed in the oocyte (Hor-
ner et al., 2003).
In addition to G
 
s
 
, the maintenance of meiotic prophase
arrest requires an orphan member of the G protein–coupled
receptor family, GPR3 (Mehlmann et al., 2004; Ledent et al.,
2005). GPR3 was identified in a mouse oocyte cDNA library
by a search for seven-transmembrane proteins (Mehlmann et
al., 2004) and was of particular interest because the overex-
pression of GPR3 in various cell lines had been shown to ele-
vate cAMP (Eggerickx et al., 1995; Uhlenbrock et al., 2002;
Bresnick et al., 2003). 
 
Gpr3
 
 RNA is highly localized in the
oocyte  versus the surrounding somatic cells, and in 
 
Gpr3
 
knockout mice, the majority of oocytes in antral follicles re-
sume meiosis spontaneously (Mehlmann et al., 2004; Ledent et
al., 2005). Oocytes in 
 
Gpr3
 
 
 
/
 
 
 
 preantral follicles remain ar-
rested in prophase, but as antral spaces begin to form between
the somatic cells (early antral stage), the oocytes resume meio-
sis independently of an increase in luteinizing hormone. As a
consequence of this disruption of the normal coordination of
meiotic progression and fertilization, 
 
Gpr3
 
 knockout females
are subfertile (Ledent et al., 2005). The spontaneous progres-
sion of meiosis that occurs in 
 
Gpr3
 
 knockout oocytes can be
reversed by an injection of 
 
Gpr3
 
 RNA into preantral follicle-
enclosed oocytes followed by culture to the early antral/antral
stage (Mehlmann et al., 2004). It is thought that GPR3 in the
oocyte maintains meiotic arrest by activating G
 
s
 
; however, this
has not been directly tested.
We investigated this hypothesis by taking advantage of
two properties of G
 
s
 
 that have been established in somatic cells:
the activation of G
 
s
 
 causes its 
 
 
 
 subunit to move from the
plasma membrane to the cytoplasm (Rasenick et al., 1984;
Ransnas et al., 1989; Levis and Bourne, 1992; Wedegaertner et
al., 1996; Iiri et al., 1997; Thiyagarajan et al., 2002; Yu and Ra-
senick, 2002; Hynes et al., 2004; Allen et al., 2005) and also to
be degraded at an increased rate (see Discussion). We com-
pared the localization of G
 
 
 
s
 
 in follicle-enclosed oocytes from
 
Gpr3
 
 
 
/
 
 
 
 and 
 
Gpr3
 
 
 
/
 
 
 
 mice by using immunofluorescence and
G
 
 
 
s
 
GFP and found that GPR3 causes the ratio of G
 
 
 
s
 
 in the
oocyte plasma membrane versus the cytoplasm to decrease.
GPR3 also causes the total amount of G
 
 
 
s
 
 protein in the oocyte
to decrease. Both of these properties indicate that GPR3 acti-
vates G
 
s
 
 in the oocyte. We then used the G
 
 
 
s
 
 distribution to
determine whether the presence of follicle cells is necessary to
keep GPR3 active in the oocyte.
 
Results
 
The localization of G
 
 
 
s
 
 in 
 
Gpr3
 
 knockout 
and wild-type oocytes indicates that 
GPR3 activates G
 
s
 
 in the oocyte
 
To investigate whether GPR3 activates G
 
s
 
 in the mouse oocyte,
we compared the plasma membrane-to-cytoplasm distribution
of G
 
 
 
s
 
 in 
 
Gpr3
 
 
 
/
 
 
 
 and 
 
Gpr3
 
 
 
/
 
 
 
 oocytes. To avoid the problem
that 
 
Gpr3
 
 
 
/
 
 
 
 oocytes within early antral and antral follicles
spontaneously resume meiosis, which would complicate a di-
rect comparison with 
 
Gpr3
 
 
 
/
 
 
 
 oocytes, we performed these ex-
periments using preantral follicles (120–190-
 
 
 
m diam). These
preantral follicles contained oocytes with 
 
 
 
70-
 
 
 
m diam that
were not yet competent to resume meiosis when isolated
(Erickson and Sorensen, 1974). At this stage, GPR3 is not re-
quired to maintain meiotic arrest (Mehlmann et al., 2004).
However, we predicted that to ensure a continuously effective
block to the progression of meiosis, the GPR3–G
 
s
 
 regulatory
system would need to be in place before the oocyte acquires the
inherent factors that allow meiotic resumption, and results that
are described below support this prediction.
Figure 1. Immunofluorescence localization of
G s in a mouse ovary. (A) Immunoblot demon-
strating G s antibody specificity. 1  g of ovary
lysate (Gpr3
 / ) was loaded on the gel; both
the 52- and 45-kD splice variants of G s (Ro-
bishaw et al., 1986) were seen. (B) A section
of a Gpr3
 /  ovary labeled with an antibody
against G s. This ovary, which was obtained
from a mouse that had not been injected with
eCG to stimulate antral follicle formation, con-
tained mostly preantral follicles and some early
antral follicles. Follicles with 120–190- m
diam were classified as preantral, whereas
those with  200- m diam were classified as
early antral (with multiple small antral spaces)
or antral (with a single large antral space; Fig.
3 A). These categories were not completely dis-
tinct because some follicles with  200- m
diam showed a formation of antral spaces. (C)
A control section labeled with nonimmune IgG.
Confocal microscope settings and bars were
the same for B and C. 
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By using an antibody against the COOH-terminal de-
capeptide of G
 
 
 
s
 
 (Simonds et al., 1989), which specifically
recognized G
 
 
 
s
 
 in mouse ovary (Fig. 1 A), we examined the
distribution of G
 
 
 
s
 
 immunofluorescence in preantral follicle-
enclosed oocytes in frozen sections of ovaries (Fig. 1, B and C)
from 
 
Gpr3
 
 
 
/
 
 
 
 and 
 
Gpr3
 
 
 
/
 
 
 
 mice. These sections showed that
G
 
 
 
s
 
 was present at a high level in theca/interstitial cells that
surround each follicle and in the oocyte. G
 
 
 
s
 
 was also present
at lower levels in the follicular somatic cells.
In 
 
Gpr3
 
 
 
/
 
 
 
 oocytes, G
 
 
 
s
 
 fluorescence was present in both
the plasma membrane and in the cytoplasm; within the cyto-
plasm, irregularly shaped bright spots up to several micrometers
in diameter as well as diffuse fluorescence were visible in most
sections (Fig. 2, A and C). In 
 
Gpr3
 
 
 
/
 
 
 
 oocytes, G
 
 
 
s
 
 was more
strongly localized in the plasma membrane (Fig. 2, B and C).
Intensity measurements (Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200506194/DC1) showed that in 
 
Gpr3
 
 
 
/
 
 
 
oocytes, the G
 
 
 
s
 
 fluorescence was higher in the plasma mem-
brane and lower in the cytoplasm than in Gpr3
 /  oocytes (Ta-
ble I). For each oocyte, we determined the plasma membrane-
to-cytoplasm fluorescence intensity ratio and found that the
mean ratio was significantly smaller for Gpr3
 /  oocytes than
for Gpr3
 /  oocytes (Fig. 2 D). These results show that GPR3
causes G s to move from the oocyte plasma membrane to the cy-
toplasm; the simplest interpretation of this observation is that
GPR3 activates Gs.
The localization of G s in oocytes from 
preantral and antral follicles indicates 
that GPR3 in the oocyte is already fully 
active at the preantral stage
To test whether the G s distribution in oocytes in Gpr3
 /  pre-
antral follicles was similar to that in oocytes in Gpr3
 /  early
antral and antral follicles, we compared the oocyte plasma
membrane-to-cytoplasm G s fluorescence ratio for follicles in
the 120–190- m diam range (preantral) with that for follicles
in the 200–475- m diam range (early antral and antral; Fig. 3,
A–D). The ratios were the same for oocytes within follicles of
the two size ranges, indicating that the level of Gs activation in
preantral follicle-enclosed oocytes is the same as in early antral
and antral follicle-enclosed oocytes. These results indicated
that the GPR3 in the oocyte is already fully active at the prean-
tral stage. Consistent with this conclusion, oocytes from prean-
tral versus early antral and antral follicles contained almost the
same amounts of Gpr3 RNA, with slightly more Gpr3 RNA in
the oocytes from preantral follicles (Fig. 3 E).
Additional evidence that GPR3 activates 
Gs in the oocyte
As another test of whether GPR3 activates Gs in the oocyte, we
compared the amount of G s protein in Gpr3
 /  with Gpr3
 / 
oocytes because the activation of Gs increases the rate of degra-
dation of its   subunit (see Discussion). Oocytes were dis-
sected from preantral follicles, and the amount of G s protein
in each sample was then analyzed by immunoblotting (Fig. 2 E).
The amount of G s was found to be 2.2–3.6 times greater in the
Figure 2. Immunofluorescence localization and immunoblotting of G s in
oocytes in Gpr3
 /  and Gpr3
 /  ovaries. (A and B) G s in Gpr3
 /  (A) and
Gpr3
 /  (B) oocytes in a preantral follicle. The confocal microscope settings
and bars were the same for A and B; the dark region in each oocyte is the
nucleus. (C) Pixel intensity on a scale of 0–255 along a line drawn through
each oocyte image, choosing a line that avoided the nucleus. (D) Plasma
membrane-to-cytoplasm G s fluorescence ratios for Gpr3
 /  and Gpr3
 / 
oocytes, which were determined as described in Fig. S1 (available at http:/
/www.jcb.org/cgi/content/full/jcb.200506194/DC1). Mean   SEM
(error bars; n   number of oocytes). The fluorescence ratios for Gpr3
 / 
oocytes (3.6   0.3) and Gpr3
 /  oocytes (13.4   1.3) were significantly
different (t test, P   0.0001). Data are from two Gpr3
 /  and two Gpr3
 / 
mice; ovaries from mice of the two genotypes were processed in parallel.
(E) Immunoblot comparing the amount of G s protein in Gpr3
 /  and
Gpr3
 /  oocytes that were isolated from preantral follicles. 15 oocytes per
lane. The 52-kD splice variant of G s is predominant in mouse oocytes,
although a small amount of the 45-kD form is present (Fig. 4 B; Mehl-
mann et al., 2002).
Table I. G s immunofluorescence intensities for the plasma 
membrane and cytoplasm of Gpr3
 /  and Gpr3
 /  oocytes
Region of intensity 
measurement Gpr3
 /  Gpr3
 / 
Plasma membrane 
intensity 91   4 (n   27)
a  191   13 (n   15)
a
Cytoplasm intensity 29   2 (n   27)
b  16    2 (n   15)
b
G s immunofluorescence intensities in the plasma membrane and cytoplasm of
Gpr3
 /  and Gpr3
 /  oocytes were measured as described in Fig. S1. Except
for the detector gain, the confocal microscope settings were the same for all
measurements; differences in gain were adjusted for by multiplying by constant
conversion factors. Intensities are expressed as equivalent values at detector gain
800 on a scale of 0–255. Mean   SEM (n   number of oocytes). Data are from
two Gpr3
 /  and two Gpr3
 /  mice. Ovaries from mice of the two genotypes
were processed in parallel.
aThese two values are significantly different (t test, P   0.0001).
bThese two values are significantly different (t test, P   0.0001).JCB • VOLUME 171 • NUMBER 2 • 2005 258
Gpr3
 /  oocytes versus the Gpr3
 /  oocytes (range for two
independent experiments, each with two to three sets of 15
oocytes of each genotype).
Consistent with the conclusion that GPR3 activates Gs in
the oocyte, the injection of Gpr3 RNA increased the amount
of cAMP in isolated Gpr3
 /  oocytes ( 1.7 times under the
conditions of these measurements; supplemental Materials
and methods, available at http://www.jcb.org/cgi/content/full/
jcb.200506194/DC1). However, the process of oocyte isola-
tion, which is necessary for such assays, changes the amount
of cAMP in the oocyte (Tornell et al., 1990); this limits the
usefulness of biochemical measurements of cAMP to detect
Gs activation by GPR3 in this system. Instead, we developed
an optical method to monitor GPR3 activation in live oocytes.
G sGFP as a monitor of GPR3 activation 
in live oocytes
To confirm our immunofluorescence results and to establish a
method for investigating GPR3 activation in live oocytes, we
examined the GPR3 dependence of G s distribution by using a
GFP fusion protein. To validate the use of G sGFP as a moni-
tor of receptor activation, we showed that in oocytes expressing
an exogenous  -adrenergic receptor and exposed to isoprotere-
nol, G sGFP moved from the plasma membrane to the cyto-
plasm, as previously described for somatic cells (supplemental
Results and Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200506194/DC1).
Preantral follicle-enclosed oocytes were injected with
RNA encoding the   subunit of Gs fused with GFP (G sGFP;
Hynes et al., 2004), were cultured overnight to allow protein
expression, and were imaged with a confocal microscope while
the oocytes were still within their follicles (Fig. 4 A). Under the
conditions of these experiments, G sGFP was expressed at a
level only slightly greater than that of endogenous G s (Fig. 4 B).
This level of G sGFP expression did not disrupt the normal
physiology of the oocyte, as indicated by the resumption of
meiosis in G sGFP-expressing oocytes that were isolated from
antral follicles (supplemental Results).
In  Gpr3
 /  oocytes, G sGFP was present in both the
plasma membrane and the cytoplasm; the cytoplasmic fluores-
cence included both diffuse and particulate components (Fig.
4 C). In contrast, in Gpr3
 /  oocytes, G sGFP was highly lo-
calized in the plasma membrane (Fig. 4 D). This difference in
G sGFP fluorescence distribution in the oocyte could not be at-
tributed to an optical difference in the surrounding follicle cells
because the follicles used were similar in size and optical density
for the two genotypes. Quantitation of G sGFP fluorescence
(Fig. S1) showed that the plasma membrane-to-cytoplasm fluo-
rescence ratio was smaller for Gpr3
 /  oocytes than for Gpr3
 / 
oocytes (Fig. 4 E), as was also observed with G s immuno-
fluorescence (Fig. 2 D). Although the ratios that were obtained
by the two methods were close, they were not identical; factors
such as fixation or overexpression artifacts could possibly ac-
count for this lack of exact correspondence.
To determine whether GPR3 in the oocyte could account
for the difference in G sGFP localization in oocytes from
Gpr3
 /  and Gpr3
 /  mice, we injected Gpr3
 /  oocytes within
preantral follicles with a mixture of Gpr3 RNA and G sGFP
RNA, cultured the follicles overnight, and observed them with
confocal microscopy. If GPR3 in the oocyte is responsible for
causing the G sGFP plasma membrane-to-cytoplasm ratio to
decrease, we would expect that the injection of Gpr3
 /  oocytes
with Gpr3 RNA would decrease the relative amount of G sGFP
in the plasma membrane versus the cytoplasm.
In Gpr3
 /  oocytes that had been injected with 7 pg of a
control RNA ( -globin), G sGFP was highly localized in the
plasma membrane (Fig. 5, A and D), as in Gpr3
 /  oocytes that
were injected with G sGFP RNA alone (Fig. 4, D and E). In
contrast, in Gpr3
 /  oocytes that had been injected with 7 pg of
Gpr3 RNA, G sGFP fluorescence was present in the cytoplasm
Figure 3. Immunofluorescence localization of G s in oocytes
within preantral and early antral/antral follicles of Gpr3
 / 
ovaries. (A) Low magnification view of a section of an antral
follicle labeled with the G s antibody. Inset shows a prean-
tral follicle. The detector gain was the same for both images.
(B and C) High magnification view of the oocyte in the prean-
tral (B) and antral (C) follicle shown in A. The confocal micro-
scope settings and bars were the same for B and C. (D)
Plasma membrane-to-cytoplasm fluorescence ratios for oo-
cytes in preantral follicles (3.2   0.2) or early antral/antral
follicles (3.6   0.2). Mean   SEM (error bars; n   number
of oocytes). The ratios were not significantly different (t test,
P   0.09). Data are from two Gpr3
 /  mice, one of which
was injected with eCG 43 h before ovary collection to in-
crease the number of antral follicles. (E) RT-PCR to compare
the amount of Gpr3 RNA in oocytes from preantral and early
antral/antral follicles. The indicated numbers of microliters of
cDNA were used for each RT-PCR; 1  l cDNA was derived
from 0.08 oocytes (supplemental Materials and methods). A
mixture of primers for Gpr3 and Rpl19 was included in each
reaction. The ratios of band intensities for Gpr3 and Rpl19
PCR products in each lane of the gel were used to obtain a
relative measure of the amount of Gpr3 RNA per oocyte. The
relative amount of Gpr3 RNA in oocytes from preantral folli-
cles compared with oocytes from early antral/antral follicles
was 1.3–1.6 (range for this and another similar experiment).G PROTEIN REGULATION OF MEIOTIC ARREST • FREUDZON ET AL. 259
and was not localized in the plasma membrane (Fig. 5 B). As the
amount of Gpr3 RNA was reduced while keeping the amount
of G sGFP RNA constant, the fraction of G sGFP in the
plasma membrane increased. The injection of 7 fg Gpr3 RNA
resulted in a plasma membrane-to-cytoplasm fluorescence ratio
that was comparable with that in Gpr3
 /  oocytes (compare
Fig. 5, C and D with Fig. 4, C and E). Similar results were ob-
tained by using a GPR3-RFP construct, which allowed us to
monitor the level of GPR3 expression as a function of the
amount of RNA injected and to show that the amount of GPR3
protein correlates with the amount of G sGFP internaliza-
tion (supplemental Results and Fig. S3, available at http://
www.jcb.org/cgi/content/full/jcb.200506194/DC1). Because an
increase in the relative amount of G s in the cytoplasm versus the
plasma membrane is an indicator of Gs activation, these find-
ings confirm that within the oocyte, GPR3 activates Gs.
GPR3 constitutively activates Gs in the 
oocyte independently of follicle cells
One way in which the somatic cells of antral and early antral
follicles could maintain prophase arrest in the oocyte is by
producing a ligand that increases the activity of GPR3. Alter-
natively, the follicle cells could inhibit meiotic resumption by
another pathway such as activating another Gs-linked receptor
Figure 4. G sGFP fluorescence in Gpr3
 /  and Gpr3
 /  pre-
antral follicle-enclosed oocytes. (A) Scanning transmission
and fluorescence images of a Gpr3
 /  preantral follicle in
which the oocyte had been injected with G sGFP RNA 20 h
before. In the transmitted light image of the oocyte, the bright
sphere on the left is an oil drop that was introduced by micro-
injection; the nucleus and nucleolus are visible on the top
right. In the fluorescence image, the oil drop and nucleus ap-
pear as dark areas where G sGFP is excluded. (B) Immuno-
blot comparing the amount of G sGFP and endogenous G s
in G sGFP RNA-injected and noninjected oocytes from a
Gpr3
 /  mouse. Oocytes were injected with the RNA while
inside their preantral follicles; after culturing the follicles over-
night, the oocytes were isolated, and gel samples were pre-
pared (14 oocytes per lane). The blot was probed with an
antibody against G s (RM). The ratio of G sGFP protein in
the injected oocytes to G s in uninjected control oocytes
was 1.1–1.5 (range for two experiments). The expression of
G sGFP caused some reduction of endogenous G s pro-
tein. (C and D) G sGFP fluorescence in Gpr3
 /  (C) and
Gpr3
 /  (D) oocytes. (C) Fluorescence is present in the
plasma membrane, in spots in the cytoplasm, and diffusely
within the cytoplasm. (D) Fluorescence is present primarily in
the plasma membrane. The confocal microscope settings and
bars were the same for C and D. (E) Plasma membrane-to-cyto-
plasm fluorescence ratios for Gpr3
 /  and Gpr3
 /  oocytes.
Mean   SEM (error bars; n   number of oocytes). Ratios for
Gpr3
 /  oocytes (3.1   0.2) and Gpr3
 /  oocytes (7.1  
0.4) were significantly different (t test, P   0.0001). Data
are from three Gpr3
 /  and three Gpr3
 /  mice.
Figure 5. G sGFP fluorescence in Gpr3
 / 
preantral follicle-enclosed oocytes that had
been coinjected with G sGFP RNA and Gpr3
RNA. Oocytes were injected with 15 pg G s-
GFP RNA and the indicated amounts of Gpr3
or a control RNA encoding  -globin, and the
follicles were cultured overnight before imag-
ing. (A–C) 7 pg  -globin (A), Gpr3 (B), and 7
fg Gpr3 (C) RNA. The confocal microscope
settings and bars were the same for all im-
ages. (D) Plasma membrane-to-cytoplasm G s-
GFP fluorescence ratios for Gpr3
 /  oocytes
that were injected with the indicated RNAs.
Mean   SEM (error bars; n   number of oo-
cytes). Data are from three mice. For the im-
ages of oocytes that had been injected with 7
pg  Gpr3 RNA (n    10), no plasma mem-
brane fluorescence could be identified, so no
ratio was calculated. Ratios for oocytes that
were injected with 7 pg  -globin RNA (7.4  
0.5) or 7 fg Gpr3 RNA (2.6   0.2) were significantly different (t test, P   0.0001). The ratio for Gpr3
 /  oocytes   7 fg Gpr3 RNA was not different
from that for Gpr3
 /  oocytes (Fig. 4 E; P   0.14), and the ratio for Gpr3
 /  oocytes   7 pg  -globin RNA was not different from that for Gpr3
 / 
oocytes (Fig. 4 E; P   0.69).JCB • VOLUME 171 • NUMBER 2 • 2005 260
in the oocyte, inhibiting the breakdown of cAMP by a PDE in
the oocyte, or supplying cAMP to the oocyte by way of gap
junctions (see Discussion). To test the first of these possibilities,
we examined whether the GPR3 stimulation of G s requires the
presence of follicle cells.
Because the immunofluorescence results described in
Fig. 3 indicated that the GPR3–Gs complex is equally active in
oocytes in preantral and in antral and early antral stage folli-
cles, we performed these experiments using oocytes from pre-
antral follicles, which have the important technical advantage
of not resuming meiosis when isolated. This allowed us to
measure the G sGFP distribution that was established after
the injection of G sGFP RNA into isolated oocytes.
Oocytes were isolated from Gpr3
 /  and Gpr3
 /  preantral
follicles, injected with G sGFP RNA, cultured overnight, and
imaged by confocal microscopy. The difference in G sGFP
localization between Gpr3
 /  and Gpr3
 /  oocytes was still
evident, indicating that GPR3 activates Gs even in the absence
of follicle cells (Fig. 6).
A comparison of plasma membrane-to-cytoplasm fluo-
rescence ratios from follicle-enclosed and isolated oocytes is
complicated by optical factors (see next paragraph). However,
by dividing the plasma membrane-to-cytoplasm fluorescence
ratio for Gpr3
 /  oocytes by the plasma membrane-to-cyto-
plasm fluorescence ratio for Gpr3
 /  oocytes, we obtained a
measure of GPR3-dependent Gs activation that could be di-
rectly compared for follicle-enclosed and isolated oocytes
(Table II, right column). This analysis indicated that the folli-
cle cells do not increase the activation of Gs by GPR3.
The measurements in Table II also showed that the abso-
lute values for plasma membrane-to-cytoplasm ratios of G s-
GFP fluorescence were greater in the isolated oocytes versus
the follicle-enclosed oocytes regardless of the presence of
GPR3. We suspected that this difference resulted, at least in
part, because confocal imaging of an isolated oocyte involves
light traveling through  35  m of optically clear medium to
reach the plasma membrane versus  35  m of optically dense
cytoplasm to reach the cytoplasmic imaging plane in the center
of the oocyte. As a consequence, the plasma membrane of iso-
lated oocytes appears artificially brighter (Fig. 7 A). A follicle-
enclosed oocyte is free of this artifact because the paths to the
cytoplasm and membrane both involve light travelling through
cytoplasm (either follicle cell cytoplasm or oocyte cytoplasm;
Fig. 7 A).
To determine the magnitude of this optical effect, we in-
jected preantral follicle-enclosed oocytes with RNA-encoding
YFP attached to the palmitoylation domain of neuromodulin
(YFP-Mem) in order to introduce a fluorescent marker of the
plasma membrane that should be independent of signals from
the follicle cells. We also injected these oocytes with YFP pro-
tein, which stays in the cytoplasm, in an amount that resulted in
a fluorescence ratio for the plasma membrane (YPF-Mem) to
cytoplasm (YFP) that was similar to that of oocytes expressing
G sGFP. We then imaged their fluorescence before and after
removal from the follicle (Fig. 7, B and C). These measure-
ments indicated that to directly compare G sGFP ratios in iso-
lated oocytes with those in follicle-enclosed oocytes, we need
to use a correction factor of 2.2 times (Fig. 7). This value fits
well with another measurement of the absorbance of light by
the mouse oocyte cytoplasm (Terasaki, 2005).
After correction for this optical factor, the plasma mem-
brane-to-cytoplasm G sGFP fluorescence ratios for follicle-
enclosed and isolated oocytes were much closer (Table II,
second and third columns). For the Gpr3
 /  oocytes, a small
but statistically significant difference remained, which could
indicate some effect of the follicle cells on Gs activity. However,
with regard to the Gpr3-dependent activation of Gs (Table II,
third column), the presence of follicle cells had no detectable
stimulatory effect. Therefore, although GPR3 and Gs are required
Figure 6. G sGFP fluorescence in Gpr3
 /  and Gpr3
 /  oocytes that were
isolated from preantral follicles and injected with G sGFP RNA. (A and B)
Gpr3
 /  and Gpr3
 /  oocytes. The confocal microscope settings and
bars were the same for A and B. (C) Plasma membrane-to-cytoplasm fluo-
rescence ratios for Gpr3
 /  (8.8   0.8) and Gpr3
 /  oocytes (21.8  
1.2). Mean   SEM (error bars; n   number of oocytes). The ratios for
Gpr3
 /  and Gpr3
 /  oocytes were significantly different (t test, P  
0.0001). Data are from two Gpr3
 /  and two Gpr3
 /  mice.
Table II. The GPR3-dependent activation of Gs in the oocyte is 
independent of follicle cells
PM/CYTO PM/CYTO PM/CYTO (Gpr3
 / )
Specimen (Gpr3
 / )( Gpr3
 / ) PM/CYTO (Gpr3
 / )
Follicle-enclosed
oocytes
d
3.1   0.2
(n   22)
a
7.1   0.4
(n   30)
b
2.3   0.2
c
Isolated oocytes
e 8.8   0.8
(n   19)
21.8   1.2
(n   18)
2.5   0.3
c
Isolated oocytes 
(with optical
correction)
4.1   0.5
(n   19)
a
10.1   1.0
(n   18)
b
–
Second and third columns indicate the ratios of plasma membrane G sGFP
fluorescence (PM) to cytoplasm G sGFP fluorescence (CYTO) in the oocyte.
Mean   SEM (n   number of oocytes). Data for follicle-enclosed oocytes are
from three mice of each genotype, and data for isolated oocytes are from two
mice of each genotype. For each row, the last column indicates the value listed
in the third column divided by the value listed in the second column. See the last
section of Results and Fig. 7 for an explanation of the optical correction.
aThese two values are not significantly different (t test, P   0.08).
bThese two values are significantly different (t test, P   0.01).
cThese two values are not significantly different (t test, P   0.6).
dCorresponds to Fig. 4 E.
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to maintain meiotic arrest in a follicle-enclosed oocyte (Mehl-
mann et al., 2002, 2004; Kalinowski et al., 2004; Ledent et al.,
2005), the signal from follicle cells that maintains meiotic ar-
rest acts by a mechanism other than providing a ligand that
activates GPR3.
Discussion
Optical methods have provided important insights about the
function of G proteins and their receptors in intact cells; in this
study, we applied such methods to study receptor–G protein
interactions in a cell (the oocyte) within an intact tissue (the
ovarian follicle). Our results showed that GPR3, which is a
member of the G protein–coupled receptor family that is re-
quired to maintain meiotic arrest, constitutively activates the
Gs G protein in the mouse oocyte.
GPR3 activates Gs in the mouse oocyte
To determine whether GPR3 activates Gs in the oocyte, we ex-
amined the distribution of G s in Gpr3 knockout and wild-type
oocytes within their follicles. The activation of Gs causes its  
subunit to dissociate from the plasma membrane, thus provid-
ing a way to examine the activation of Gs in single cells within
tissues. Translocation of the activated   subunit of Gs into the
cytoplasm has been demonstrated in somatic cells by fraction-
ation of soluble and particulate components (Rasenick et al.,
1984; Ransnas et al., 1989; Levis and Bourne, 1992; Wede-
gaertner et al., 1996; Jones et al., 1997; Huang et al., 1999;
Thiyagarajan et al., 2002; Yu and Rasenick, 2002), by immu-
nofluorescence microscopy (Wedegaertner et al., 1996; Iiri
et al., 1997; Thiyagarajan et al., 2002), and, most recently,
by GFP fusion protein microscopy (Yu and Rasenick, 2002;
Hynes et al., 2004; Allen et al., 2005).
In particular, these microscopic methods have shown a
consistent correlation between Gs activation and translocation
of its   subunit from the plasma membrane into the cytoplasm
whether Gs is activated by a receptor, by cholera toxin, or by
point mutation. In addition, G s is not internalized in response
to receptor stimulation if the   subunit is point mutated such
that its activation is impaired (Iiri et al., 1997). We validated
the use of G s localization as an indicator of its activation in
oocytes by showing that G sGFP moves from the oocyte
plasma membrane to the cytoplasm when an exogenously ex-
pressed  -adrenergic receptor is stimulated with isoproterenol.
Incorporation of GFP into an internal sequence of G s
does not prevent receptor-mediated activation of GTP-binding
and adenylyl cyclase (Yu and Rasenick, 2002; Hynes et al.,
2004). The G sGFP fusion protein that we used, which in-
cludes a linker sequence on either side of the inserted GFP, is
almost identical to G s in terms of the receptor-mediated activa-
tion of adenylyl cyclase (Hynes et al., 2004). We used G sGFP
as well as immunofluorescence to visualize the G s distribution
within follicle-enclosed oocytes. Both localization methods
showed that the ratio of G s in the plasma membrane versus cy-
toplasm is smaller in Gpr3
 /  oocytes than in Gpr3
 /  oocytes,
indicating that GPR3 activates Gs. The injection of Gpr3 RNA
into Gpr3
 /  oocytes restored the G sGFP distribution that is
characteristic of Gpr3
 /  oocytes, showing that GPR3 in the
oocyte is sufficient to maintain the activity of Gs in the oocyte.
The mechanism of G s internalization is incompletely
understood (Hynes et al., 2004; Allen et al., 2005), but depalm-
itoylation of the activated   subunit is likely to be an important
factor (Wedegaertner and Bourne, 1994; Wedegaertner et al.,
1996; Thiyagarajan et al., 2002). G s is then repalmitoylated
(Jones et al., 1997) and, as a consequence, is thought to associ-
ate with intracellular membranes for transport back to the
plasma membrane (Wedegaertner et al., 1996; Hynes et al.,
2004). Dissociation of   from    subunits could also contrib-
ute to G s internalization, but whether such dissociation occurs
during Gs activation is unknown (Frank et al., 2005).
Bright spots of G s fluorescence within the cytoplasm of
Gpr3
 /  oocytes are suggestive of an association of G s with
clusters of intracellular membranes. Punctate localization of G s
has been seen in somatic cells after receptor activation (Wede-
gaertner et al., 1996; Yu and Rasenick, 2002; Hynes et al., 2004;
Allen et al., 2005), and, in these cells, colocalization of G s with
the monomeric G protein RAB11 supports the idea that G s as-
sociates with vesicles for recycling to the plasma membrane
(Hynes et al., 2004). Because the G s accumulations in oocytes
Figure 7. Determination of the optical correction factor for comparing the
plasma membrane-to-cytoplasm fluorescence ratios in preantral follicle-
enclosed and isolated oocytes. (A) Diagram of the optical difference in
comparing follicle-enclosed with isolated oocytes. (B) YFP-Mem and YFP
fluorescence from an oocyte in a preantral follicle. (C) YFP-Mem and YFP
fluorescence from the same oocyte as shown in B after isolation from its
follicle. The detector gain for B was 3.2 times that for C, reflecting the fact
that the fluorescence intensity collected from an oocyte inside a preantral
follicle is less than that collected from an isolated oocyte. Other confocal
microscope settings and bars were the same for B and C. The plasma
membrane-to-cytoplasm fluorescence ratio that was measured for B was
3.5 and that for C was 8.2. Based on measurements of 14 such oocytes,
removal from the follicle resulted in an increase in the apparent plasma
membrane-to-cytoplasm fluorescence ratio of 2.2   0.2 (mean   SEM);
data from two mice.JCB • VOLUME 171 • NUMBER 2 • 2005 262
are up to several micrometers in diameter and are irregular in
shape, and because the fluorescence is present throughout the
spots rather than at their peripheries, these spots are unlikely to
be single vesicles; whether they function in the recycling of G s
to the oocyte plasma membrane remains to be determined.
As another test of whether GPR3 activates Gs in the oocyte,
we compared the amount of G s protein in oocytes that had been
isolated from Gpr3
 /  or Gpr3
 /  follicles. The activation of
G s by cholera toxin, point mutation, or receptor activation in-
creases its rate of degradation (Levis and Bourne, 1992; Morav-
cová et al., 2004). Thus, a decrease in G s protein is an indicator
of Gs activation. We found that the amount of G s protein in
Gpr3
 /  oocytes was approximately three times that in Gpr3
 / 
oocytes, indicating that the presence of GPR3 reduces the
amount of G s protein. This finding, as well as our finding that
GPR3 overexpression elevates cAMP in the oocyte, are addi-
tional evidence that GPR3 activates Gs in the mouse oocyte.
For somatic cells, it has been speculated that one function
of the internalization and degradation of activated G s may be
signal attenuation; internalization of G s potentially separates it
from the receptor that activates it and from adenylyl cyclase,
both of which are localized in the plasma membrane (Wede-
gaertner and Bourne, 1994). However, for the maintenance of
meiotic arrest in oocytes, it is not clear why attenuation of the Gs
signal would be useful. Another proposed function of internal-
ization of G s is to allow it to interact with molecules in the cyto-
plasm (Wedegaertner and Bourne, 1994). In the oocyte, much of
the adenylyl cyclase 3 protein is found in the cytoplasm (Horner
et al., 2003), so the internalization of G s could allow it to acti-
vate this pool of adenylyl cyclase as well as regulate other cyto-
plasmic proteins such as tubulin (Roychowdhury et al., 1999).
These results tie together previous findings that both
GPR3 (Mehlmann et al., 2004; Ledent et al., 2005) and Gs
(Mehlmann et al., 2002; Kalinowski et al., 2004) are required
to maintain meiotic arrest and support the conclusion that
GPR3–Gs interaction is responsible for the activation of ade-
nylyl cyclase that maintains elevated cAMP in the oocyte, thus
maintaining meiotic prophase arrest.
GPR3 activity in the oocyte is not 
increased by the presence of follicle cells
In somatic cells, GPR3 expression elevates cAMP apparently in-
dependently of an extracellular ligand (Eggerickx et al., 1995;
Uhlenbrock et al., 2002; Bresnick et al., 2003). Likewise, our
measurements of G sGFP distribution indicate that even without
the follicle cells, GPR3 activates Gs in the oocyte. Previous
studies have also shown that Gs is active in follicle-free oocytes
because the injection of a G s inhibitory antibody or a dominant-
negative form of G s overcomes the inhibition of spontaneous
meiotic resumption by a cAMP PDE inhibitor (Mehlmann et al.,
2002; Kalinowski et al., 2004). However, this previous work did
not quantitatively compare Gs activity in oocytes with and with-
out the follicle cells. Based on the G sGFP distribution, we now
conclude that the follicle cells have no detectable effect on
GPR3-dependent Gs activity in the oocyte. Instead, GPR3 ap-
pears to be either inherently active or activated by a molecule
within the oocyte cytoplasm or plasma membrane.
How follicle cells signal to the oocyte to maintain meiotic
arrest is unknown. Our results indicate that the target of the folli-
cle cell signal is not GPR3 but do not exclude the possibility that
the follicle cell signal activates a different, unidentified Gs-linked
receptor that could be present in the oocyte membrane. The small
but statistically significant difference in the plasma membrane-
to-cytoplasm ratio of G sGFP, comparing follicle-enclosed with
isolated oocytes from Gpr3
 /  mice, suggests a role for a second
Gs-linked receptor. Another possible explanation of the meiosis-
inhibiting effect of follicle cells is that additional cAMP enters
the oocyte from follicle cells by way of gap junctions (Anderson
and Albertini, 1976; Piontkewitz and Dekel, 1993; Webb et al.,
2002; Eppig et al., 2004). Although this has been a long-standing
hypothesis, it has not been definitively tested.
Alternatively, follicle cells could reduce cAMP PDE ac-
tivity in the oocyte. Consistent with a role for a PDE inhibitor
in maintaining meiotic arrest, oocytes from mice lacking the
PDE3A isoform remain in prophase when isolated (Masciarelli
et al., 2004). In addition, cilostamide-sensitive cAMP PDE ac-
tivity in cumulus cell–oocyte complexes increases with time
after isolation from the follicle; because cilostamide is an in-
hibitor of the oocyte-specific PDE3A isoform, this finding in-
dicates that the presence of follicle cells may suppress oocyte
PDE activity (Richard et al., 2001). Mouse follicular fluid con-
tains the PDE inhibitor hypoxanthine, which is an effective in-
hibitor of meiotic resumption in isolated oocytes (Eppig et al.,
1985). However, because the concentration of hypoxanthine in
follicular fluid is not precisely known, its physiological signifi-
cance is uncertain (Eppig et al., 1985; Eppig, 1991).
Although follicular fluid alone has some inhibitory effect
on meiotic resumption in isolated oocytes, the inhibition is
stronger when there is contact between the somatic cells and
the oocyte (Tsafriri and Channing, 1975; Racowsky and Bald-
win, 1989). This suggests that somatic cell molecules that act
on the oocyte are, at least in part, membrane associated rather
than free in the follicular fluid. The somatic cells extend pro-
cesses that contact the oocyte; these contacts may be the sites
where the meiosis-inhibiting signal is transmitted to the oocyte
(Anderson and Albertini, 1976).
Although our findings argue against stimulation of GPR3
activity in the oocyte by an agonist from the follicle cells, GPR3
activity could be inhibited by an inverse agonist when luteinizing
hormone acts on the somatic cells to cause meiosis to resume in
the oocyte (Eppig et al., 2004; Park et al., 2004; Mehlmann,
2005). GPR3 is related to the melanocortin receptors (Joost and
Methner, 2002), and the melanocortin-4 receptor shows constitu-
tive activity that is inhibited by an endogenous inverse agonist,
agouti-related protein (Nijenhuis et al., 2001).
Two sequential but overlapping 
mechanisms for maintaining meiotic 
prophase arrest
The GPR3–Gs mechanism for maintaining meiotic prophase ar-
rest becomes necessary only at the early antral stage; at the pre-
antral stage, meiotic arrest does not require GPR3 (Mehlmann
et al., 2004) or the presence of follicle cells (Erickson and So-
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cles are incompetent to resume meiosis is unknown. Cell cycle
regulatory protein levels have not been compared in oocytes
from preantral with early antral follicles, but a comparison of
 55- m diam oocytes from 12-d-old mice with  80- m diam
oocytes from antral follicles of adult mice has shown that the
small oocytes contain lower concentrations of cyclin B and
CDK1 (Kanatsu-Shinohara et al., 2000). It is possible that the
concentrations of these proteins, which are essential for meiotic
resumption, stay low until the early antral stage.
Although the GPR3–Gs system is not required at the pre-
antral stage, GPR3 is already present and activating Gs. Thus,
as seems logical, the oocyte establishes the GPR3–Gs regula-
tory system before the oocyte becomes competent to resume
meiosis, therefore ensuring that progression to metaphase does
not precede the luteinizing hormone signal.
Materials and methods
Mice
Gpr3 knockout mice were obtained from Deltagen, Inc. and were geno-
typed as previously described (Mehlmann et al., 2004). Ovaries were col-
lected from 20–25-d-old mice. For Fig. 3, one mouse was injected inter-
peritoneally with 5 IU equine chorionic gonadotropin (eCG; provided by
A.F. Parlow, National Hormone and Peptide Program, Torrance, CA). All
animal studies were approved by the University of Connecticut Health
Center Animal Care Committee.
Isolation and culture of follicles and oocytes
Preantral follicles (120–190- m diam) and early antral/antral follicles
(250–430- m diam) were dissected from ovaries by using Dumont mini
forceps (11200-14; Fine Science Tools). For some experiments, oocytes
were isolated from the dissected follicles by using 30-gauge needles; re-
sidual follicle cells were removed by mouthpipetting through a micropi-
pette that had been cut with a diamond knife (10100-00; Fine Science
Tools) such that the inner diameter at the end was  60  m. All manipula-
tions were performed in MEM  medium (12000-022; Invitrogen) supple-
mented with 25 mM NaHCO3, 75  g/ml penicillin G, 50  g/ml strepto-
mycin sulfate, and 5% FBS (16000-044; Invitrogen).
For overnight culture of preantral follicles, the medium also contained
5  g/ml insulin, 5  g/ml transferrin, 5 ng/ml selenium (all from Sigma-
Aldrich), and 10 ng/ml ovine follicle stimulating hormone (National Hormone
and Peptide Program). 4–10 follicles were placed on Millicell culture plate
inserts (PICMORG50; Millipore) inside coverslip-bottomed dishes (P35G-0-
20-C-INV; MatTek Corp.) containing 1.6 ml of medium. The dishes were
thoroughly rinsed with MEM  before use. The cultures were maintained at
37 C with 5% CO2 in humidified air for 20–34 h before imaging. Isolated
oocytes were cultured in 200  l MEM  drops containing 5% FBS under
light mineral oil (Fisher Scientific) for 21–28 h before imaging.
Immunoblotting
An ovary was homogenized in 100  l PBS with protease inhibitors by us-
ing a 0.1-ml Dounce homogenizer. Oocytes were isolated from preantral
follicles as described above. An affinity-purified antibody against the
COOH-terminal decapeptide of G s (RM) was provided by A. Spiegel
(National Institutes of Health, Bethesda, MD) and used at 1.7  g/ml; blots
were developed by using ECL Plus reagents (GE Healthcare).
Immunofluorescence microscopy
Ovaries were fixed in 4% PFA (Electron Microscopy Sciences) in PBS for
3 h at 4 C, rinsed in PBS, incubated in 30% sucrose for 1–2 h, and trans-
ferred to freezing medium (H-TFM; Triangle Biomedical Sciences, Inc.) in
6-mm–diam gelatin capsules (5214; Ernest F. Fullam, Inc.). The samples
were frozen in isopentane that was cooled with dry ice, and 8–10- m sec-
tions were cut using a cryostat. The sections were blocked with 1% BSA
and 5% normal goat serum in PBS, stained using 3  g/ml G s antibody
or 3.6  g/ml nonimmune rabbit IgG (MP Biomedicals) and 20  g/ml of
a fluorescein-labeled goat anti–rabbit secondary antibody (MP Biomedi-
cals), and mounted with Vectashield mounting medium (Vector Laborato-
ries). The sections were imaged by using a confocal microscope (LSM
510; Carl Zeiss MicroImaging, Inc.) with the pinhole set for an optical sec-
tion thickness of 3  m. Fluorescence was excited with the 488-nm line of
an argon laser and was detected by using a 500–550-nm emission filter.
Tile scans as shown in Fig. 1 (B and C) were collected by using a 20 
NA 0.75 Fluar objective (Carl Zeiss MicroImaging, Inc.) and were used to
identify follicles for imaging with a 40  NA 1.2 water immersion objec-
tive (C-Apoachromat; Carl Zeiss MicroImaging, Inc.). For these and all
other images, the photomultiplier amplifier offset was adjusted so that the
baseline was above zero, and the gain was adjusted so that peak intensi-
ties were not saturated.
Plasma membrane and cytoplasmic fluorescence intensities were
measured by using MetaMorph software (Molecular Devices) as de-
scribed in Fig. S1 and in supplemental Materials and methods. For the
analysis of G s immunofluorescence images, we subtracted a background
value that was determined by measuring the fluorescence intensity of oo-
cytes in sections that were processed in parallel but incubated with nonim-
mune IgG instead of the anti-G s primary antibody. These background in-
tensity values, which, for different sets of sections, ranged from three to
seven on a scale of 0–255, have been subtracted from the G s fluores-
cence intensity values shown in Table I, but the figures are shown without
background subtraction.
Microinjection
Preantral follicle-enclosed oocytes and isolated oocytes were injected
while held between coverslips that were separated by a piece of dou-
ble stick tape that formed a 100- m spacer (Video 1, available at
http://www.jcb.org/cgi/content/full/jcb.200506194/DC1; Jaffe and
Terasaki, 2004; Mehlmann et al., 2004). The preantral follicles (120–
190- m diam) were partially pulled into the coverslip space by applying
suction with a mouth-controlled pipette and were pushed in further using
the microinjection pipette. This flattened the follicles such that the oocytes
could be seen clearly for injection. After injection, the follicles were swept
out of the coverslip space by using the microinjection pipette such that
they fell into the reservoir of medium that was formed by the injection
slide. All injection volumes were 15 pl and were calibrated as previously
described (Jaffe and Terasaki, 2004). For experiments in which follicle-
enclosed oocytes were injected with RNA-encoding YFP-Mem, a second
injection of YFP protein was performed after overnight culture; this was
accomplished by putting the follicle-enclosed oocyte back into the cover-
slip space on an injection slide.
RNAs and protein used for injection 
RNA-encoding G sGFP was transcribed from a cDNA that was identical
to  s-CFP, as described previously by Hynes et al. (2004), except that
ECFP was replaced by EGFP. This construct, which was in the vector
pcDNAI/Amp (Invitrogen), was linearized with XbaI, and RNA was tran-
scribed using T7 polymerase (mMessage mMachine; Ambion). The cDNA
for mouse Gpr3 (D21062) in pHGCX was as described previously by
Saeki et al. (1993) and Mehlmann et al. (2004). The cDNA for mouse
Gpr3-RFP consisted of the monomeric form of RFP (mRFP1, AF506027.1;
Campbell et al., 2002) fused to the COOH terminus of mouse Gpr3 and
inserted into the vector pHGCY. mRFP1 cDNA was provided by R.Y. Tsien
(University of California, San Diego, San Diego, CA). Gpr3 and Gpr3-RFP
cDNAs were linearized with PacI, and RNA was transcribed using T7
polymerase. pSP64-X m, which is a plasmid containing Xenopus laevis
 -globin cDNA, was obtained from D.A. Melton (Harvard University,
Cambridge, MA) and linearized with PstI; RNA was transcribed using SP6
polymerase. The cDNA for the rat  2 adrenergic receptor (Adrb2) in
pBluescript SK  was obtained from N. Ancellin (GlaxoSmithKline, Les
Ulis, France) and linearized with Not1; RNA was transcribed using T7
polymerase. The YFP membrane marker pEYFP-Mem (BD Biosciences) was
subcloned into pBluescript II SK  and linearized with SapI; RNA was tran-
scribed using T7 polymerase.
Except where indicated, an  200-bp poly(A) tail was added to
RNAs by incubation with Escherichia coli poly(A) polymerase I (Ambion;
Aida et al., 2001) followed by LiCl precipitation and resuspension in nu-
clease-free water. RNA concentrations were estimated by a comparison
with RNA standards (Ambion) that were run on an agarose gel. Except
where indicated, the G sGFP RNA concentration was adjusted to  1
 g/ l such that a 15-pl injection introduced 15 pg/oocyte. YFP-Mem
RNA was used at  1 pg/oocyte. Amounts of other RNAs are indicated
in the text. YFP protein was made in bacteria by using EYFP (BD Bio-
sciences) subcloned into pRSETA (Invitrogen), and the protein was puri-
fied on a Ni–nitrilotriacetic acid column (QIAGEN) and a HiTrap Q HP
column (GE Healthcare), concentrated using a 10,0000 MWCO centrifu-
gal filter device (Amicon Ultra-4; Millipore), and used at a concentration
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Imaging of live follicles and oocytes
Follicles were imaged while held on a Millicell membrane over a cover-
slip-bottomed dish (see Isolation and culture...oocytes). Isolated oocytes
were imaged while held in 5- l droplets under light mineral oil on a cover-
slip-bottomed dish. The dishes were placed within a covered microscope
stage (Carl Zeiss MicroImaging, Inc.) maintained at 37 C; water-saturated
5% CO2 in air was passed through the chamber. The follicles and oocytes
were imaged by using a confocal microscope (LSM 510; Carl Zeiss Micro-
Imaging, Inc.), with the pinhole set for an optical section thickness of 5  m,
and a 40  NA 0.8 water immersion objective (Achroplan; Carl Zeiss
MicroImaging, Inc.). GFP fluorescence was excited with the 488-nm line
of an argon laser and was detected by using a 500–550-nm emission fil-
ter. YFP fluorescence was excited with the 514-nm line of an argon laser
and was detected by using a longpass 530-nm emission filter. RFP fluores-
cence was excited with the 543-nm line of a HeNe laser and was detected
by using a longpass 560-nm emission filter.
Plasma membrane and cytoplasm intensities were measured by us-
ing MetaMorph software (Fig. S1 and supplemental Materials and meth-
ods). For both GFP and YFP images, controls using uninjected oocytes
within preantral follicles showed no detectable difference in intensity
when comparing the oocyte and surrounding follicle cells. Therefore, in-
tensity measurements in follicle-enclosed oocytes expressing GFP or YFP
were referenced with respect to the baseline fluorescence intensity in the
surrounding follicle cells. Controls using uninjected oocytes that had been
isolated from their follicles sometimes showed slightly higher autofluores-
cence than the surrounding medium (depending on the detector gain, a
mean of zero to two units on a scale of 0–255). For those cases in which
the oocyte autofluorescence was greater than one unit, it was subtracted
from the fluorescence intensity values before calculating the plasma mem-
brane-to-cytoplasm fluorescence ratio; figures are shown without back-
ground subtraction.
Statistics
Tests of statistical significance were performed by using Instat (GraphPad
Software). For Table II, the SEM resulting from the division of one mean  
SEM divided by another mean   SEM was calculated by using an equa-
tion for error propagation (http://www.rit.edu/~uphysics/uncertainties/
Uncertaintiespart2.html).
Online supplemental material
Video 1 shows the microinjection of a preantral follicle-enclosed mouse
oocyte. The supplemental Materials and methods section describes the use
of MetaMorph software to measure plasma membrane and cytoplasm in-
tensities (Fig. S1) as well as methods for RT-PCR and cAMP measurements.
The supplemental Results section shows that G sGFP expression does not
prevent the spontaneous resumption of meiosis in oocytes that were iso-
lated from antral follicles, that G sGFP moves from the oocyte plasma
membrane to the cytoplasm when an exogenously expressed  -adrenergic
receptor is stimulated with isoproterenol (Fig. S2), and that the amount of
GPR3 protein expression correlates with the amount of G sGFP internal-
ization (Fig. S3). Fig. S1 shows the quantitation of plasma membrane-to-
cytoplasm fluorescence ratios. Fig. S2 shows the distribution of G sGFP in
an oocyte coexpressing the  2-adrenergic receptor before and 30 min af-
ter exposure to 10  M isoproterenol. Fig. S3 shows images of preantral
follicle-enclosed Gpr3
 /  oocytes coexpressing GPR3-RFP and G sGFP.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200506194/DC1.
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